Literature DB >> 28603767

Lumbar puncture in patients with neurologic conditions.

Rosha Babapour Mofrad1,2, Femke H Bouwman2, Rosalinde E R Slot2, Tessa Timmers2, Wiesje M van der Flier2,3, Philip Scheltens2, Charlotte E Teunissen1,2.   

Abstract

A lumbar puncture is performed to obtain cerebral spinal fluid. It is implemented in the clinic on a routine basis to aid the diagnosis of neurologic diseases, such as dementia. This video will show the lumbar puncture procedure as routinely performed in the VUmc Alzheimer Center.

Entities:  

Keywords:  Alzheimer's disease; Educational video; Lumbar puncture; Lumbar puncture video; Neurologic disease

Year:  2017        PMID: 28603767      PMCID: PMC5454130          DOI: 10.1016/j.dadm.2017.04.008

Source DB:  PubMed          Journal:  Alzheimers Dement (Amst)        ISSN: 2352-8729


Introduction

This article accompanies an informative lumbar puncture (LP) Video in which we illustrate how to perform an LP in neurologic diseases. Our aim is to provide a reference for educational purposes and to give an update on the state of the art. We wish to help reduce the reluctance in performing an LP by demonstrating an LP method based on recently published consensus guidelines by Engelborghs et al. [1] aiming to minimize the risk of complications. Moreover, we aim to demonstrate the utility of the LP as an aid in the diagnosis of neurodegenerative diseases, notably Alzheimer's disease. These are the first steps toward standardizing the LP procedure, which will help to implement cerebrospinal fluid (CSF) biomarkers in clinical practice [2]. Target audience: Our target audience includes trainees in neurology and other clinicians who perform an LP for diagnostic or scientific reasons. Moreover, the Video is informative for scientists who use CSF material and want to increase their awareness of the procedure. We do wish to emphasize that this Video can serve as a basis for practical supervised training. This Video shows the recommendations based on consensus guidelines by Engelborghs et al. [1]; every professional can choose to deviate from these recommendations when deemed necessary. The following section describes the LP procedure as routinely performed in the VUmc Alzheimer Center.

Materials and methods

Preparation

Patient instructions

Various studies have shown that one of the risk factors for experiencing post-LP complications is the actual fear of the LP procedure and post-LP complications by the patient [1]. This fear may be reduced by giving adequate information to the patient before and during the procedure. Providing visual support, such as showing a model of the lower back, is recommended. The importance of flexing the back and relaxation during the procedure should be emphasized. This creates more intervertebral space while inserting the needle, thereby increasing the chances of a successful procedure. The patient should also be informed of the most prevalent possible complications, which consist of post-LP back pain (17%), typical post-LP headache (PLPH) (9%), and atypical headache (19%) [1], [3].

Allergies and contraindications

The physician should check for allergies to bandages, latex, alcohol, or iodine as well as for possible contraindications. The most important contraindications include an intracranial space occupying lesion with mass effect or abnormal intracranial pressure, the use of oral anticoagulant medication, coagulopathies and uncorrected bleeding diathesis, and a local skin infection at the puncture site. For more information on contraindications and allergies we refer to the consensus guidelines by Engelborghs et al. [1].

Materials

Before performing the LP, it is essential to prepare all equipment. To reduce the risk of infection an aseptic technique is applied using the following materials: A 25-gauge needle with a stylet Polypropylene collection tubes Sterile gloves and sterile field Sterile and nonsterile gauzes Iodine or alcohol Bandage Protective mat For (1) a needle with a small diameter, higher than 24 gauge, has proven to reduce the risk of post-LP complaints [1]. An atraumatic needle is recommended by authors of most studies because that will result in a lower incidence of PLPH, but it is not used in the Video, because it results in more attempts and failures of the LP procedure, when performed by less experienced clinicians [1]. It is important to keep in mind that when intracranial pressure measurement is necessary needles smaller than 22 gauge are not suitable [1]. A syringe may be convenient for collection of large volumes (>10 mL), but the use of a syringe is associated with an increased risk of post-LP complaints and is an additional step that leads to absorption of proteins [1], [4].

LP procedure

Positioning

The LP can be performed in both the sitting and the lateral recumbent position. The position depends on the physician's preferences and the patient's clinical condition. In the sitting position the patient is positioned with his back toward the physician, leaning forward as far as possible, thus maximizing the space between spinal processes. The spinal processes should be perpendicular to the floor, to ensure that the needle is inserted in the midline. The lateral recumbent position, however, is recommended because of a lower risk of severe headache [1]. If needed, this position is the only way to perform intracranial pressure measurement [1]. In the lateral recumbent position, the patient is asked to lie down on the side and to flex the back by pulling the knees to the chest. The knees and shoulders are placed in the same plane to make sure the spinal processes are aligned. In both the sitting and the lateral recumbent position the back should be flexed as far as possible to generate more space between the lumbar spinal processes so the needle can be inserted more easily. The physician should verify with the patient that this position can be maintained for a sufficient period of time before starting the procedure.

CSF withdrawal

When the patient is positioned properly the physician locates the site of needle insertion by palpating the posterior superior iliac crest and follow it in a straight line to the lumbar spinal processes. This line indicates the position of the fourth lumbar vertebral body. The needle can be safely inserted into the subarachnoid space at the L3-4, L4-5, or L5-S1 interspace, because this is well below the lower end of the spinal cord. The space between two lumbar spinal processes is palpated. This is followed by disinfection of the area with alcohol in a circular motion. The physician puts on sterile gloves and checks the position of the patient again because the patient may have slightly changed position. Then the area is disinfected again with a sterile gauze, after which the needle is inserted in midline aiming at the umbilicus of the patient. When the subarachnoidal space is reached, a loss of resistance is typically felt. The needle is positioned properly when CSF starts dripping after removal of the stylet. CSF is collected in a polypropylene tube. When no fluid is detected or bone is encountered the needle will be redrawn until the subcutaneous level and inserted again at a different angle, or the needle is completely removed and a new attempt is made at an interspace at a different level. A maximum of four attempts is advised; however, this depends on the clinical need [1]. When the suitable amount of CSF is collected, the stylet is positioned back before the needle is removed as this has shown to reduce post-LP complaints [1]. A bandage is placed at the site of insertion when the needle is removed. The physician should stay in contact with the patient during the entire procedure to describe the following steps of the procedure and to give reassurance.

Concluding the procedure

After the LP the patient remains lying for a few moments and gets up slowly when feeling well. Studies have shown that bed rest is not associated with a lower prevalence of PLPH or post-LP back pain [1]. The patient is provided with printed information on possible complications and how to react when they occur.
  3 in total

1.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Harald Hampel; José Luis Molinuevo; Kaj Blennow; Steven T DeKosky; Serge Gauthier; Dennis Selkoe; Randall Bateman; Stefano Cappa; Sebastian Crutch; Sebastiaan Engelborghs; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; Marie-Odile Habert; Gregory A Jicha; Agneta Nordberg; Florence Pasquier; Gil Rabinovici; Philippe Robert; Christopher Rowe; Stephen Salloway; Marie Sarazin; Stéphane Epelbaum; Leonardo C de Souza; Bruno Vellas; Pieter J Visser; Lon Schneider; Yaakov Stern; Philip Scheltens; Jeffrey L Cummings
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

2.  Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.

Authors:  Flora H Duits; Pablo Martinez-Lage; Claire Paquet; Sebastiaan Engelborghs; Alberto Lleó; Lucrezia Hausner; José L Molinuevo; Erik Stomrud; Lucia Farotti; Inez H G B Ramakers; Magda Tsolaki; Constance Skarsgård; Ragnar Åstrand; Anders Wallin; Martin Vyhnalek; Marie Holmber-Clausen; Orestes V Forlenza; Laura Ghezzi; Martin Ingelsson; Erik I Hoff; Gerwin Roks; Alexandre de Mendonça; Janne M Papma; Andrea Izagirre; Mariko Taga; Hanne Struyfs; Daniel A Alcolea; Lutz Frölich; Mircea Balasa; Lennart Minthon; Jos W R Twisk; Staffan Persson; Henrik Zetterberg; Wiesje M van der Flier; Charlotte E Teunissen; Philip Scheltens; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2015-09-11       Impact factor: 21.566

3.  Consensus guidelines for lumbar puncture in patients with neurological diseases.

Authors:  Sebastiaan Engelborghs; Ellis Niemantsverdriet; Hanne Struyfs; Kaj Blennow; Raf Brouns; Manuel Comabella; Irena Dujmovic; Wiesje van der Flier; Lutz Frölich; Daniela Galimberti; Sharmilee Gnanapavan; Bernhard Hemmer; Erik Hoff; Jakub Hort; Ellen Iacobaeus; Martin Ingelsson; Frank Jan de Jong; Michael Jonsson; Michael Khalil; Jens Kuhle; Alberto Lleó; Alexandre de Mendonça; José Luis Molinuevo; Guy Nagels; Claire Paquet; Lucilla Parnetti; Gerwin Roks; Pedro Rosa-Neto; Philip Scheltens; Constance Skårsgard; Erik Stomrud; Hayrettin Tumani; Pieter Jelle Visser; Anders Wallin; Bengt Winblad; Henrik Zetterberg; Flora Duits; Charlotte E Teunissen
Journal:  Alzheimers Dement (Amst)       Date:  2017-05-18
  3 in total
  7 in total

1.  P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles.

Authors:  Kirsten E J Wesenhagen; Betty M Tijms; Lynn Boonkamp; Patty L Hoede; Julie Goossens; Nele Dewit; Philip Scheltens; Eugeen Vanmechelen; Pieter Jelle Visser; Charlotte E Teunissen
Journal:  Alzheimers Res Ther       Date:  2022-07-15       Impact factor: 8.823

Review 2.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

Review 3.  Amsterdam Dementia Cohort: Performing Research to Optimize Care.

Authors:  Wiesje M van der Flier; Philip Scheltens
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 4.  State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease.

Authors:  Harald Hampel; Leslie M Shaw; Paul Aisen; Christopher Chen; Alberto Lleó; Takeshi Iwatsubo; Atsushi Iwata; Masahito Yamada; Takeshi Ikeuchi; Jianping Jia; Huali Wang; Charlotte E Teunissen; Elaine Peskind; Kaj Blennow; Jeffrey Cummings; Andrea Vergallo
Journal:  Alzheimers Dement       Date:  2021-05-27       Impact factor: 16.655

5.  Deciphering the factors that influence participation in studies requiring serial lumbar punctures.

Authors:  Gregory S Day; Tracy Rappai; Sushila Sathyan; John C Morris
Journal:  Alzheimers Dement (Amst)       Date:  2020-02-06

6.  Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies.

Authors:  M van de Beek; R Babapour Mofrad; I van Steenoven; H Vanderstichele; P Scheltens; C E Teunissen; A W Lemstra; W M van der Flier
Journal:  Alzheimers Res Ther       Date:  2020-04-17       Impact factor: 6.982

7.  Lumbar puncture patient video increases knowledge and reduces uncertainty: An RCT.

Authors:  Rosha Babapour Mofrad; Agnetha D Fruijtier; Leonie N C Visser; Nina Hoogland; Maisa van Dijk; Frederique van Rossum; Femke H Bouwman; Ellen M A Smets; Charlotte E Teunissen; Wiesje M van der Flier
Journal:  Alzheimers Dement (N Y)       Date:  2021-02-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.